Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
astrazeneca
4
×
biotech
4
×
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
4
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
pfizer
allergan
amgen
biogen
bristol-myers squibb
cancer
clinical trials
covid-19
deals
eli lilly
What
bio
roundup
acquisitions
ceo
daniel
drug
gilead
o’day
sciences
seven
announced
august
away
biggest
biotech
bringing
build
busy
buy
ceos
collabs
company’s
covid
days
dc
deal
debut
decisions
devices
drugs
dyne’s
executives
fda
gathered
gilead’s
groups
hearing
held
help
introduce
Language
unset
Current search:
astrazeneca
×
biotech
×
novartis
×
" raleigh-durham blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away